| pubmed-article:2117834 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2117834 | lifeskim:mentions | umls-concept:C0025320 | lld:lifeskim |
| pubmed-article:2117834 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:2117834 | lifeskim:mentions | umls-concept:C0024264 | lld:lifeskim |
| pubmed-article:2117834 | lifeskim:mentions | umls-concept:C0021745 | lld:lifeskim |
| pubmed-article:2117834 | lifeskim:mentions | umls-concept:C0021747 | lld:lifeskim |
| pubmed-article:2117834 | lifeskim:mentions | umls-concept:C0441472 | lld:lifeskim |
| pubmed-article:2117834 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:2117834 | lifeskim:mentions | umls-concept:C2003941 | lld:lifeskim |
| pubmed-article:2117834 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
| pubmed-article:2117834 | lifeskim:mentions | umls-concept:C0443172 | lld:lifeskim |
| pubmed-article:2117834 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:2117834 | pubmed:dateCreated | 1990-9-25 | lld:pubmed |
| pubmed-article:2117834 | pubmed:abstractText | The authors analyze their findings in the study on the effects of interferon preparations (immune gamma-interferon and recombinant alpha 2-interferon) on the ability of blood lymphocytes of dermatoses patients and normal subjects to enter the rosette formation. Preliminary cell treatment with gamma-interferon in vitro essentially influences lymphocytic rosette forming activity, the initial functional activity of cellular receptor system being of paramount importance here. gamma-interferon increased cellular rosette-forming activity and virtually did not influence the unchanged parameters in the patients with lowered values by spontaneous and early active E-RFC. Besides that immune interferon increased the count of 'heavy' rosettes detectable in spontaneous and active E-rosette formation. Recombinant alpha 2-interferon did not essentially alter the blood lymphocyte receptor system. | lld:pubmed |
| pubmed-article:2117834 | pubmed:language | rus | lld:pubmed |
| pubmed-article:2117834 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2117834 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2117834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2117834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2117834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2117834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2117834 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2117834 | pubmed:issn | 0042-4609 | lld:pubmed |
| pubmed-article:2117834 | pubmed:author | pubmed-author:MedunitsynN... | lld:pubmed |
| pubmed-article:2117834 | pubmed:author | pubmed-author:AvdeevaZh... | lld:pubmed |
| pubmed-article:2117834 | pubmed:author | pubmed-author:MazinaN MNM | lld:pubmed |
| pubmed-article:2117834 | pubmed:author | pubmed-author:OlisovaM OMO | lld:pubmed |
| pubmed-article:2117834 | pubmed:author | pubmed-author:KrylovO ROR | lld:pubmed |
| pubmed-article:2117834 | pubmed:author | pubmed-author:LukashevaT... | lld:pubmed |
| pubmed-article:2117834 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2117834 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2117834 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2117834 | pubmed:pagination | 16-9 | lld:pubmed |
| pubmed-article:2117834 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:2117834 | pubmed:meshHeading | pubmed-meshheading:2117834-... | lld:pubmed |
| pubmed-article:2117834 | pubmed:meshHeading | pubmed-meshheading:2117834-... | lld:pubmed |
| pubmed-article:2117834 | pubmed:meshHeading | pubmed-meshheading:2117834-... | lld:pubmed |
| pubmed-article:2117834 | pubmed:meshHeading | pubmed-meshheading:2117834-... | lld:pubmed |
| pubmed-article:2117834 | pubmed:meshHeading | pubmed-meshheading:2117834-... | lld:pubmed |
| pubmed-article:2117834 | pubmed:meshHeading | pubmed-meshheading:2117834-... | lld:pubmed |
| pubmed-article:2117834 | pubmed:meshHeading | pubmed-meshheading:2117834-... | lld:pubmed |
| pubmed-article:2117834 | pubmed:meshHeading | pubmed-meshheading:2117834-... | lld:pubmed |
| pubmed-article:2117834 | pubmed:meshHeading | pubmed-meshheading:2117834-... | lld:pubmed |
| pubmed-article:2117834 | pubmed:meshHeading | pubmed-meshheading:2117834-... | lld:pubmed |
| pubmed-article:2117834 | pubmed:meshHeading | pubmed-meshheading:2117834-... | lld:pubmed |
| pubmed-article:2117834 | pubmed:meshHeading | pubmed-meshheading:2117834-... | lld:pubmed |
| pubmed-article:2117834 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2117834 | pubmed:articleTitle | [The immunomodulating action of interferon. The change in the rosette-forming activity of human blood lymphocytes under the influence of gamma-interferon and recombinant alpha 2-interferon]. | lld:pubmed |
| pubmed-article:2117834 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2117834 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:2117834 | pubmed:publicationType | In Vitro | lld:pubmed |
| pubmed-article:2117834 | pubmed:publicationType | English Abstract | lld:pubmed |
